F64.0
Conditions
Interventions
Group 1: Patients with confirmed female-to-male transsexualism
Group 2: Patients with confirmed male-to-female transsexualism
Group 3: Patients with confirmed female-to-male transsexualism after gende
Sponsors
Universitätsklinikum Leipzig
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Persistent, well-documented gender dysphoria. 2. Ability to provide informed consent for the treatment. 3. Legal age of majority. 4. If there are significant medical or psychological concerns, they must be well-controlled. 5. Continuous hormone therapy for 12 months, aligned with the patient's goals (unless there are medical contraindications or the patient is unable or unwilling to take hormones for other reasons). 6. Living consistently for 12 months in the gender role that matches their gender identity.
Exclusion criteria
Exclusion criteria: 1. No persistent or insufficiently documented gender dysphoria. 2. Inability to provide informed consent for the treatment. 3. Underage. 4. Uncontrolled or significant medical or psychological concerns. 5. No continuous hormone therapy for 12 months, unless there are medical contraindications or the patient is unwilling or unable to take hormones for other reasons. 6. Not living consistently for 12 months in the gender role that matches their gender identity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life, measured using the SF-36 questionnaire, depending on the surgical intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life, measured using the ETLI and Body Chest Q questionnaires, depending on the surgical intervention. | — |
Countries
Germany
Contacts
Public ContactStefan Langer
Universitätsklinikum Leipzig
Outcome results
None listed